GlassScriptPhysician profile
Mary Ann Yurko
NPI 1124012992
$3,019.42
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,812 · 2020: $1,189 · 2023: $18.47.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $18.47.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $996.53 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $576.66 | 2019-2023 | |
| Amgen INC. | $319.74 | 2019-2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $284.56 | 2019-2020 | |
| Pfizer INC. | $204.80 | 2019-2020 | |
| Genzyme Corporation | $186.75 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $74.89 | 2019-2020 | |
| Janssen Biotech, INC. | $61.98 | 2019-2020 | |
| Ucb, INC. | $47.89 | 2019-2020 | |
| Almirall LLC | $39.06 | 2019-2020 | |
| Prugen, INC. Pharmaceuticals | $37.39 | 2019 | |
| Galderma Laboratories, L.P. | $27.54 | 2019 | |
| Leo Pharma INC. | $24.87 | 2019-2020 | |
| Kyowa Kirin, INC. | $20.88 | 2020 | |
| Celgene Corporation | $19.34 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dusa Pharmaceuticals, INC. | $17.98 | 2019 | |
| Genentech USA, INC. | $16.72 | 2019 | |
| Biofrontera INC. | $15.44 | 2020 | |
| Promius Pharma LLC | $12.27 | 2019 | |
| Lilly USA, LLC | $11.69 | 2019 | |
| Mayne Pharma Commercial LLC | $11.44 | 2019 | |
| Helsinn Therapeutics (U.S.), INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Yurko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.